InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,597.12
(
-0.20%
)
US TECH 100
19,184.45
(
-0.34%
)
Dow Jones
40,834.97
(
-0.15%
)
Brent Oil
76.89
(
0.18%
)
Bitcoin
59,617.96
(
1.03%
)
Post# of 36619
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gatorca

Send PM Follow Ignore
Followers 21
Posts 1344
Boards Moderated 0
Alias Born 06/28/2020

Gatorca

Re: Bluehorseshoe66 post# 31113

Tuesday, 03/29/2022 9:36:24 AM

Tuesday, March 29, 2022 9:36:24 AM

Post# of 36619
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19



ps, sorry Blue just seen you posted the News already I still got to read it, just woke up...
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM

Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM

POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM

Start posting your company's news
Only $200 per official company press release!